Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Recently updated

FDA-approved

Showing page 90 of 200 · By data quality, then INN

  1. omadacycline tosylate

    NUZYRA

    ORAL FDA: approved

  2. omalizumab-igec

    OMLYCLO

    INJECTION FDA: approved

  3. omaveloxolone

    SKYCLARYS

    ORAL FDA: approved · EMA: approved

    N07XX25

  4. ombitasvir

    VIEKIRAX

    ORAL FDA: approved · EMA: withdrawn

    J05AP53

  5. omega-3-acid ethyl esters type a

    OMTRYG

    ORAL FDA: approved

  6. omega-3-carboxylic acids

    EPANOVA

    ORAL FDA: approved

  7. omega-3acid ethyl esters

    OMACOR

    ORAL FDA: approved

  8. omeprazole magnesium

    PRILOSEC OTC

    ORAL FDA: approved

  9. omidenepag isopropyl

    OMLONTI

    OPHTHALMIC FDA: approved

  10. onabotulinumtoxina

    BOTOX

    SINGLE-USE FDA: approved · NMPA: clinical trials

  11. orforglipron calcium

    FOUNDAYO

    ORAL FDA: approved

  12. oritavancin diphosphate

    ORBACTIV

    INTRAVENOUS FDA: approved

  13. orlistat

    XENICAL Lacuna Pharma Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    A08AB01

  14. orphenadrine citrate

    ORPHENADRINE CITRATE

    INJECTION FDA: approved

  15. orphenadrine hydrochloride

    DISIPAL

    ORAL FDA: approved

  16. osilodrostat phosphate

    ISTURISA

    ORAL FDA: approved

  17. osimertinib mesylate

    TAGRISSO

    ORAL FDA: approved

  18. ospemifene

    SENSHIO

    ORAL FDA: approved · EMA: approved

    G03XC05

  19. oteseconazole

    VIVJOA

    ORAL FDA: approved · EMA: application withdrawn

    J02

  20. oxamniquine

    VANSIL

    ORAL FDA: approved

  21. oxandrolone

    OXANDROLONE

    ORAL FDA: approved

  22. oxaprozin potassium

    DAYPRO ALTA

    ORAL FDA: approved

  23. oxiconazole nitrate

    OXICONAZOLE NITRATE

    TOPICAL FDA: approved

  24. oxprenolol hydrochloride

    TRASICOR

    ORAL FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.